TY - PAT
T1 - Treatment Of Sickle Cell Disease
AU - Essack, Magbubah
AU - Bajic, Vladimir B.
AU - Radovanovic, Aleksandar
N1 - KAUST Repository Item: Exported on 2019-02-13
PY - 2014/12/4
Y1 - 2014/12/4
N2 - The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
AB - The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
UR - http://hdl.handle.net/10754/595349
UR - http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220140356458%22.PGNR.&OS=DN/20140356458&RS=DN/20140356458
UR - http://assignment.uspto.gov/#/search?adv=publNum:20140356458
UR - http://www.google.com/patents/US20140356458
UR - http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2014356458A1&KC=A1&FT=D
M3 - Patent
M1 - US9655905B2
ER -